SERPINA12 and type 2 diabetes mellitus: Visceral adipose tissue-derived serine proteinase inhibitor (vaspin) was identified in the visceral adipose tissue of OLETF (Otsuka Long-Evans Tokushima Fatty) rats, which are used in an animal model of obesity and type 2 diabetes [1].